Stock A068270 CELLTRION, INC.
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Celltrion, Inc.

News Celltrion, Inc.

Equities

A068270

KR7068270008

End-of-day quote Korea Stock Exchange
Other stock markets
 06:00:00 2023-11-29 pm EST 		Intraday chart for Celltrion, Inc. 5-day change 1st Jan Change
162,900.00 KRW +0.74% -5.78% +1.50%
Nov. 14 Celltrion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Nov. 09 Celltrion, Inc. authorizes a Buyback Plan. CI

Summary

Search
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Regeneron Sues Celltrion For Proposed Biosimilar Of Eylea In West Virginia District Court
AQ
Celltrion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Celltrion, Inc. authorizes a Buyback Plan.
CI
Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on October 23, 2023.
CI
Celltrion, Inc. announces an Equity Buyback for 1,314,286 shares.
CI
Celltrion's Net Income Jumps in Q3
MT
Celltrion, Inc.'s Equity Buyback announced on October 23, 2023, has closed with 2,426,161 shares, representing 1.71% for KRW 365,096.41 million.
CI
South Korean shares fall after four straight sessions of gain
RE
Celltrion Healthcare to Provide Turkmenistan with Two Anti-Cancer Medications
MT
Celltrion Announces FDA Approval Of ZYMFENTRA (Infliximab-dyyb)
AQ
Celltrion, Inc. authorizes a Buyback Plan.
CI
Celltrion, Inc. announces an Equity Buyback for 2,426,161 shares.
CI
Celltrion Expands Access To YUFLYMA (Adalimumab-Aaty)
AQ
S.Korean shares climb ahead of US payrolls data; still down for week
RE
Relapsing Remitting Multiple Sclerosis Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)
AQ
Rani Therapeutics Starts Early Stage Trial of Autoimmune Disease Treatment Candidate
MT
Tranche Update on Celltrion, Inc.'s Equity Buyback Plan announced on August 28, 2023.
CI
Celltrion, Inc.'s Equity Buyback announced on August 28, 2023, has closed with 696,865 shares, representing 0.49% for KRW 101,946.76 million.
CI
Celltrion : ConsolidatedFS_1H FY2023
PU
South Korean Shares Close Higher as Investors Look Beyond Further Rate Hike Decision by US Fed; Celltrion Adds 1%
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Announcement Date

Since

Until

  1. Stock
  2. Equities
  3. Stock Celltrion, Inc. - Korea Stock Exchange
  4. News Celltrion, Inc.
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer